News | September 02, 2023
Biocon acquires oral solid dosage manufacturing facility of Eywa Pharma for US$7.7 million
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
The WHO - Global Center for Traditional Medicine will help member countries in taking enabling steps in their countries for strengthen education and practices of traditional mdicine
The company's consolidated revenues for the quarter grew 36% to Rs. 3,020 crore on the back of robust performance across all its three businesses
Under the soon to be launched Heal in India initiative, India aims to provide its health infrastructure for patients abroad and make it a global hub for medical and value-based healthcare for patients from across the world
This ambitious anti-TB campaign, as part of IOCL’s CSR, aims to ensure early identification of presumptive TB and prompt diagnosis using high-sensitivity diagnostic tests at the doorstep
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
Under the terms of this agreement Biocon will be responsible for the manufacturing and supply of Liraglutide to Zentiva, for its commercialization across 30 countries in Europe
MeitY will provide technical support for digitalisation of the Ayush Sector under the Ayush Grid project for a period of three years
Subscribe To Our Newsletter & Stay Updated
